Delivery Order SPE2DR25D1017-SPE2DR26F9AXV
- Not listed
- The Defense Logistics Agency awarded a $5,579.73 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to the vendor's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $8,764.26. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 22, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,358.85 for Trulicity 1.5 mg/0.5 mL pens on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single pharmaceutical supply transaction to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $1,744.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL quantity) on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance...
- The Defense Logistics Agency awarded a $5,317.77 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 and extends through December 2026. The product will be delivered to AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $3,856.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 12, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,862.58 on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 12, 2025, and performance executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,351.35. This is a firm fixed-price delivery order with an ultimate completion date of June 10, 2025, and represents a non-competitive award under DLA's pharmaceutical supply chain. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,455.72 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on December 12, 2025, with an ultimate completion date of December 15, 2025. This non-competitive, firm fixed-price delivery order will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,868.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9AXVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with a ceiling value of $4,035.46. This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and U.S. military healthcare systems. As a prime vendor under the DLA's comprehensive pharmaceutical supply vehicle, the company fulfills a broad portfolio of pharmaceutical products and medical supplies supporting military health programs worldwide. This delivery order for Trulicity, an injectable diabetes medication, exemplifies the company's ongoing role in supplying brand-name pharmaceutical products to federal healthcare consumers through competitively awarded transactions with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 12/4/25 |